本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.85
-0.1600-7.96%
盘后:1.870.0198+1.07%19:55 EDT
成交量:90.17万
成交额:171.06万
市值:2.21亿
市盈率:-1.32
高:2.00
开:1.99
低:1.85
收:2.01
52周最高:5.55
52周最低:1.03
股本:1.20亿
流通股本:1.09亿
量比:0.92
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-1.4029
每股收益(LYR):-1.2813
净资产收益率:-179.10%
总资产收益率:-62.95%
市净率:19.34
市盈率(LYR):-1.44

数据加载中...

2022/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/15

重要事件披露

8-K - Current report
2021/11/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/17

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933